These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34579542)

  • 1. Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions.
    Diaby V; Ali A; Babcock A; Fuhr J; Braithwaite D
    J Manag Care Spec Pharm; 2021 Sep; 27(9-a Suppl):S22-S29. PubMed ID: 34579542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using latent class and quantum models to value equity in health care: a tale of 2 stories.
    Ngorsuraches S
    J Manag Care Spec Pharm; 2021 Sep; 27(9-a Suppl):S12-S16. PubMed ID: 34579543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Importance of Economic Perspective and Quantitative Approaches in Oncology Value Frameworks of Drug Selection and Shared Decision Making.
    Waldeck AR; Botteman MF; White RE; van Hout BA
    J Manag Care Spec Pharm; 2017 Jun; 23(6-a Suppl):S6-S12. PubMed ID: 28535105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Frameworks That Provide Value Measures for Health Care Interventions.
    Mandelblatt JS; Ramsey SD; Lieu TA; Phelps CE
    Value Health; 2017 Feb; 20(2):185-192. PubMed ID: 28237193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].
    Garrison LP; Neumann PJ; Willke RJ; Basu A; Danzon PM; Doshi JA; Drummond MF; Lakdawalla DN; Pauly MV; Phelps CE; Ramsey SD; Towse A; Weinstein MC
    Value Health; 2018 Feb; 21(2):161-165. PubMed ID: 29477394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verifying the value of existing frameworks for formulary review at a large academic health system: assessing inter-rater reliability.
    Karas BL; Picone MF; Werner S; Holsopple M
    J Manag Care Spec Pharm; 2021 Apr; 27(4):488-496. PubMed ID: 33769852
    [No Abstract]   [Full Text] [Related]  

  • 8. Reflections on the ISPOR Special Task Force on U.S. Value Frameworks: Implications of a Health Economics Approach for Managed Care Pharmacy.
    Garrison LP; Neumann PJ; Willke RJ
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1185-1192. PubMed ID: 31663458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Multicriteria Approaches to Assess the Value of Health Care.
    Phelps CE; Madhavan G
    Value Health; 2017 Feb; 20(2):251-255. PubMed ID: 28237204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using latent class and quantum models to value equity in health care: a tale of 2 stories.
    Ngorsuraches S
    J Manag Care Spec Pharm; 2021 Sep; 27(9-a Suppl):S14-S18. PubMed ID: 34534007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. As Value Assessment Frameworks Evolve, Are They Finally Ready for Prime Time?
    Dubois RW; Westrich K
    Value Health; 2019 Sep; 22(9):977-980. PubMed ID: 31511186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient value: Perspectives from the advocacy community.
    Addario BJ; Fadich A; Fox J; Krebs L; Maskens D; Oliver K; Schwartz E; Spurrier-Bernard G; Turnham T
    Health Expect; 2018 Feb; 21(1):57-63. PubMed ID: 28940536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1].
    Neumann PJ; Willke RJ; Garrison LP
    Value Health; 2018 Feb; 21(2):119-123. PubMed ID: 29477388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing Value Assessment in the United States: A Multistakeholder Perspective.
    Sorenson C; Lavezzari G; Daniel G; Burkholder R; Boutin M; Pezalla E; Sanders G; McClellan M
    Value Health; 2017 Feb; 20(2):299-307. PubMed ID: 28237214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5].
    Phelps CE; Lakdawalla DN; Basu A; Drummond MF; Towse A; Danzon PM
    Value Health; 2018 Feb; 21(2):146-154. PubMed ID: 29477392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-making criteria among national policymakers in five countries: a discrete choice experiment eliciting relative preferences for equity and efficiency.
    Mirelman A; Mentzakis E; Kinter E; Paolucci F; Fordham R; Ozawa S; Ferraz M; Baltussen R; Niessen LW
    Value Health; 2012 May; 15(3):534-9. PubMed ID: 22583464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions.
    Sculpher M; Claxton K; Pearson SD
    Value Health; 2017 Feb; 20(2):234-239. PubMed ID: 28237201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equity and efficiency preferences of health policy makers in China--a stated preference analysis.
    Paolucci F; Mentzakis E; Defechereux T; Niessen LW
    Health Policy Plan; 2015 Oct; 30(8):1059-66. PubMed ID: 25500745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value Assessment at the Point of Care: Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient Values.
    Armstrong MJ; Mullins CD
    Value Health; 2017 Feb; 20(2):292-295. PubMed ID: 28237212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks.
    Zhang M; Bao Y; Lang Y; Fu S; Kimber M; Levine M; Xie F
    Value Health; 2022 Feb; 25(2):302-317. PubMed ID: 35094803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.